Neuberger Berman Group »

Compass Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $69k 13k 5.37

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jan28 Now P @ 120.000000 Option Put Option (NOW)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
February 26 Calls on HD US Option Call Option (HD)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Ishares Core S&p 500 Etf Etf (IVV)
Nextera Energy Common (NEE)
Visa Inc-class A Shares Common (V)

View all positions for Neuberger Berman Group

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
Adage Capital Partners GP
State Street Corporation
BVF
FMR
Rock Springs Capital Management
Deerfield Management Company
Geode Capital Management

View all funds holding Compass Therapeutics